Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Datos Health Partners With Medial EarlySign, Augments Artificial Intelligence With Remote Care Automation To Optimize Patient Care

Collaboration will Provide Healthcare Organizations an End-to-End Solution for Early Identification and Improved Care for High-Risk Populations

Datos Health, a leader in remote care automation, and Medial EarlySign, an innovator in AI-based actionable clinical insights, announced  a collaboration to offer state-of-the-art integrated solutions to identify high-risk patients who stand to benefit from remote care programs. The solution is focused on helping providers achieve better outcomes in vulnerable populations, as they transition to value-based care.

Recommended AI News: Asirom uses Solera’s Artificial Intelligence for the Risk Inspection of Motor Policies

The collaboration combines EarlySign’s predictive solutions for identifying patients at increased risk of specific chronic or life-threatening conditions with Datos’ corresponding automated remote care programs, helping to prevent or delay the onset of disease and downstream complications. The introduction of this solution is particularly crucial as high-risk population management becomes a must-have competency for healthcare providers of all denominations, with organizations striving to deliver better preventive services across the care continuum.

Related Posts
1 of 18,094

“The transition to value-based care and pre-emptive approaches requires deeper insight into the patient population. Medial EarlySign’s AI-based clinical approach facilitates proactive and preventative treatment through earlier identification of high-risk patient trajectories when interventions stand more chance of halting or preventing the onset of disease,” said Ori Geva, CEO and Co-Founder of Medial EarlySign. “Datos provides healthcare stakeholders new options and models of intervention for these high-risk patients, including a way to seamlessly enable more frequent, or even continuous monitoring and engagement that can reduce intervention costs and significantly improve care delivery and patient outcomes.

Recommended AI News: StockSnips Inc Launches ESG News Sentiment Product

“Datos has spent the last several years focused on building a solution for personalized and automated remote care across a diverse range of disease conditions, enabling better care and a higher level of patient engagement and participation,” said Uri Bettesh, CEO and Founder of Datos Health. “The prospect of extending automated remote care to pre-disease and early onset stages opens up a new world of possibilities for the ultimate goal of keeping people healthier for longer.”

Recommended AI News: Army Research Lab Awards ICF $53 Million for Cyber Services

Leave A Reply

Your email address will not be published.